Sentences with phrase «rpe cell degeneration»

Thus, if mitochondria impairment leading to RPE cell degeneration can be predicted and confined early on, then AMD can be halted or reversed before degeneration spreads.

Not exact matches

For example, a consortium of research groups called the London Project to Cure Blindness aims to test RPE transplants from embryonic stem cells in patients with macular degeneration this year.
«It's fantastic news that they are going into the clinic with a cell therapy for eye disease,» says Pete Coffey of University College London, and head of a team developing tiny «patches» of RPEs for treating age - related macular degeneration.
The researchers detected RPE cells in the eye of the patient with Stargardt disease but not in the patient with age - related macular degeneration.
The healthy RPE cells could also be used in patients at earlier stages of these diseases, to prevent the degeneration before it starts.
The degeneration of retinal pigment epithelial (RPE) cells as a consequence of impaired mitochondria has emerged as a key feature of early - stage age - related macular degeneration (AMD).
We further expect our results to show that RPE cell - secreted vesicles are essential for cell - to - cell communication connected to spreading RPE degeneration in AMD, and therefore, potential therapeutic targets to halt vision loss in AMD.
Our findings open the way to develop therapeutic strategies to remove lipofuscin from RPE cells, which may have implications for the treatment of age - related macular degeneration in which lipofuscin accumulation in cells is a causative factor.
These findings suggest that RPE cells, derived from iPS cells, could be used to treat blindness in humans, such as blindness caused by age - related macular degeneration, a leading cause of blindness in the Western world.
A pilot study assessing the safety and feasibility of the transplantation of autologous iPSC - derived retinal pigment epithelium (RPE) cell sheets in patients with exudative (wet - type) age - related macular degeneration was launched in Japan in August 2013.
Lanza's team figured out how to coax stem cells taken from human embryos into becoming the RPE cells that die off along with photoreceptors in macular degeneration, and in 2011 the team began injecting these manufactured cells into patients» eyes.
In many forms of human retinal disease, including age - related macular degeneration (AMD), the underlying pathogenesis resides within the support cells of the retina, the retinal pigment epithelium (RPE).
The ensuing dysfunction, distress and sometimes death of the RPE cells results in age related macular degeneration.
a b c d e f g h i j k l m n o p q r s t u v w x y z